German maker Lemmo releases Lemmo 3 cargo e‑bike featuring a semi‑solid‑state batteryHuawei releases add‑on camera lens for Mate 90 Pro Max flagshipSatlyt raises $8 million to develop AI software for satellitesChief Justice William H. Rehnquist born on October 1, 1924New AI tool claims to reconstruct visual images from brain scans and predict brain activity from imagesBolivia detains attorney general amid U.S. allegations of drug‑cartel briberyNikole Hannah-Jones Discusses Choosing Catholic School for Her Daughter Over Public OptionsDiscussion Explores Meaning and Use of “Bona Fides” in Good Faith ArgumentsStartups Explore Small, Distributed Battery Solutions Amid NYC Regulatory HurdlesPoll shows Conley leads Lawler in New York's 17th Congressional District raceTurkish football fans display pro-Palestinian banners at friendly matchEurope's Competitive Position Compared to US and China Under ScrutinyIndia Set to Meet Pakistan in Asian Games Men's Cricket FinalImmigration Issue Appears to Decline in Voter Salience for Trump and GOPSen. Sherrod Brown emphasizes economic issues in Ohio, testing traditional working‑class Democratic appeal
Back to event

The Way the FDA and DEA Ban Drugs Is Unaccountable and Arbitrary

By Ryan Curtis · Sep 29, 2026, 10:40 AM CDT

Read full article at Reason
Since the beginning of the war on drugs over 55 years ago, the federal government has been classifying and regulating drugs through a "scheduling" system. A new report from the Government Accountability Office (GAO) reveals just how arbitrary scheduling decisions made by the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) can be. In the United States, the primary law r

Excerpt shown under fair-use limits. Full text remains with the original publisher.

People in this coverage

Explore their history and attributable record. Being mentioned does not imply endorsement.

Layer 1 · Claims & fact checks

AI analysis

Layer 2 · Biblical perspective

Biblical interpretation
UNHOLY / UNRIGHTEOUS
Read the biblical analysis

Layer 3 · Reporting analysis

AI analysis

Loaded LanguageThe phrase emphasizes negligence and frames the agency as incompetent.

Appeal to AuthorityThe article relies on the GAO’s authority to legitimize its critique without presenting counter‑views.

Contrast FramingThe comparison is used to argue that marijuana is less harmful, supporting the claim that scheduling is arbitrary.

Speculative AssertionThe article speculates about internal decision‑making without evidence, introducing bias.

Narrative FramingFrames drug policy as uniformly negative, ignoring nuanced outcomes or successes.

Context

AI analysis

Missing context

The piece omits details about any existing internal guidance documents, the role of the DEA’s and FDA’s scientific advisory committees, and the legal standards that agencies must follow under the CSA. It also does not mention any prior GAO findings on the same issue or how the agencies have responded to the report’s conclusions.

Important context

The GAO report focuses on the lack of formal, written policies for scheduling decisions, but it does not assess the quality of informal practices, expert consultations, or case‑by‑case scientific evaluations that may still guide DEA and FDA actions. Additionally, the article does not provide the GAO’s recommendations or any response from the agencies, which would be relevant for understanding potential reforms.

Opinion vs. reporting

AI analysis

The article mixes reporting of GAO findings (e.g., direct quotes about the absence of policies) with strong editorial commentary (e.g., describing the process as “arbitrary,” “made‑up,” and attributing motives such as “meddlesome”). The factual sections are presented alongside opinionated language, making the overall tone more persuasive than neutral.